Cipla Limited

Cipla Limited Share Value declined by 5%

Cipla Limited Share Value declined by 5% in intraday trade:

To begin with, today, the share value of Cipla Limited declines 5% in intraday trade. The company had got a warning letter from the USFDA due to that the company’s share value declined. 

The United States Food and Drug Administration gave a warning letter to the Goa-based company Cipla. The USFDA conducted the investigation process from Sep 16 to Sep 17, 2019.

As per the records, the company committed to maintaining the qualified standards of compliance. Also, it closely works with the agency for the total address of all the observations. 

The company listing with Rs 414.05 per eq share and declined by Rs 11.30 or 2.66% on the Bombay Stock Exchange. The company reached its 52-week highest share value at Rs 585.50 on 27th May 2019. Similarly, the company reached its 52-week lowest value of Rs 389.55 on 11th Oct 2019.

Presently, the company listing with 29.28% loss from 52-week highest value and 6.29% gain from 52-week lowest value.

Cipla Ltd share trading with a loss of 3.80 points reached 422.00 INR with 0.89% down. Its previous close at 425.80 INR. Cipla Ltd shares outstanding with 806,233,425.

Besides, the Sensex and Nifty trading with a bearish trend today (Feb 26th), The Sensex trading with a loss of 392.24 points reached 39,888.96with 0.97% down. Whereas Nifty trading with a loss of 119.40 points reached 11,678.50 with 1.01% down.

Related posts

Prashant Kumar: YES Bank doesn’t need an external source of funding

Tarun

Bank Holidays List for June 2020

mahesh

Telecom shares on May 19; Bharti Airtel surges almost 11%

Tarun